New hope for stuffy noses: drug 611 targets nasal polyps

NCT ID NCT06639295

First seen Jan 04, 2026 · Last updated Apr 29, 2026 · Updated 18 times

Summary

This study tests a new drug called 611 for people with chronic sinusitis and nasal polyps (growths in the nose). The goal is to see if it can shrink polyps and ease congestion better than a placebo. About 243 adults whose symptoms are not well-controlled with current treatments will take part. The study is in its final phase (Phase 3) and is not currently recruiting.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NASAL POLYPS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Site 01

    Beijing, Beijing Municipality, 100730, China

Conditions

Explore the condition pages connected to this study.